Archive: June 2022

Cases in the Management of Polycythemia Vera: Switching From Hydroxyurea to Ruxolitinib to Resolve Symptoms and Improve Quality of Life 

Case 1 of a 3-Part Series Patient Case A 65-year-old man was diagnosed with polycythemia vera (PV) 3 years ago (Table 1). He initially presented with […]

Highlights in Graft-vs-Host Disease From the 2022 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR

A Review of Selected Presentations From the 2022 Tandem Meetings • April 23-26, 2022 • Salt Lake City, Utah Noninvasive Genomic Characterization of Patients With Nonsclerotic […]

Cases in the Management of Nonmetastatic Castration-Resistant Prostate Cancer: Darolutamide Added to Leuprolide in a 73-Year-Old Patient

Case 2 of a 3-Part Series Patient Case A 73-year-old man was diagnosed with prostate cancer based on a prostate-specific antigen (PSA) level of 6.5 ng/mL. […]

Back to Archive